Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome

Table 2

Difference of serum biochemical indices between CYP39A1 low expression and CYP39A1 high expression in HCC patients.

Serum biochemical indices	CYP39A1 low expression	CYP39A1 high expression	value^a
	Alanine aminotransferase (ALT)				0.38
Aspartic transaminase (AST)			0.93
ALT/AST (ratio)			0.01
Alkaline phosphatase (ALP)			0.33
γ-Glutamyltransferase (GGT)			0.23
Total bile acid (TBA)			0.02
Prealbumin (PA)			<0.001
Total protein (TP)			0.42
Albumin (ALB)			0.09
Globulin (GLB)			0.45
Ratio of albumin to globulin (A/G)			0.01
Total bilirubin (TBIL)			0.01
Direct bilirubin (DBIL)			0.02
Leucine aminopeptidase (LAP)			0.25
Glutamate dehydrogenase (GLDH)			0.44
Fibronectin (Fn)			0.04
Urea (urea)			0.28
Creatinine (Cr)			0.01
Urea nitrogen/creatinine (U/Cr)			0.06
β2-microglobulin (β2-m)			0.06
Total carbon dioxide (TCO2)			0.19
Uric acid (UA)			0.01
Total cholesterol (TCh)			0.10
Triacylglycerol (TG)			0.62
High-density lipoprotein cholesterol (HDL-Ch)			0.79
Low-density lipoprotein cholesterin (LDL-Ch)			0.16
Total/high density lipoprotein cholesterol (T/HDL-Ch)			0.61
Lipoprotein alpha (LP(α))			0.78

^aStudent’s -test.